Ali Salanti

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Oncofetal chondroitin sulfate in cancer therapy: a promising target for anti-tumor drug delivery?

Oncofetal chondroitin sulfate in cancer therapy: a promising target for anti-tumor drug delivery?

Journal: Expert opinion on drug delivery

Published: December 18, 2025

Glycan Profiling Identifies Chondroitin-4-sulfate as a Biomarker for Platinum Response and Therapeutic Target in Ovarian Cancer.

Glycan Profiling Identifies Chondroitin-4-sulfate as a Biomarker for Platinum Response and Therapeutic Target in Ovarian Cancer.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer.

Multimodal C9-66 CAR-T cell immunotherapy improves outcome in preclinical models of pancreatic cancer.

Journal: Gut

Published: November 15, 2025

Oncofetal chondroitin sulfate positive circulating tumor cells as prognostic biomarkers in early-stage melanoma.

Oncofetal chondroitin sulfate positive circulating tumor cells as prognostic biomarkers in early-stage melanoma.

Journal: Scientific reports

Published: September 30, 2025

Preclinical profiling of antibody drug conjugates targeting oncofetal chondroitin sulfate.

Preclinical profiling of antibody drug conjugates targeting oncofetal chondroitin sulfate.

Journal: Cell death & disease

Published: May 14, 2025

Multi-cancer detection of circulating tumor cells by targeting oncofetal chondroitin sulfate.

Multi-cancer detection of circulating tumor cells by targeting oncofetal chondroitin sulfate.

Journal: NPJ precision oncology

Published: January 17, 2025

The glycosaminoglycan oncofetal chondroitin sulfate represents a novel target for antibody drug-conjugate therapy for AML.

The glycosaminoglycan oncofetal chondroitin sulfate represents a novel target for antibody drug-conjugate therapy for AML.

Journal: Blood

Published: December 20, 2024

The glycosaminoglycan oncofetal chondroitin sulfate is a novel target for antibody-drug conjugate therapy for AML.

The glycosaminoglycan oncofetal chondroitin sulfate is a novel target for antibody-drug conjugate therapy for AML.

Journal: Blood

Published: December 20, 2024

Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells.

Protocol for the creation and utilization of 3D pancreatic cancer models from circulating tumor cells.

Journal: STAR protocols

Published: October 11, 2024

Targeting Oncofoetal Chondroitin Sulphate Allows Identification of Tumour-Derived Extracellular Vesicles.

Targeting Oncofoetal Chondroitin Sulphate Allows Identification of Tumour-Derived Extracellular Vesicles.

Journal: Journal of extracellular vesicles

Published: September 06, 2024

Mammalian cell-based production of glycans, glycopeptides and glycomodules.

Mammalian cell-based production of glycans, glycopeptides and glycomodules.

Journal: Nature communications

Published: August 23, 2024

Combining rVAR2 and Anti-EpCAM to Increase the Capture Efficiency of Non-Small-Cell Lung Cancer Cell Lines in the Flow Enrichment Target Capture Halbach (FETCH) Magnetic Separation System.

Combining rVAR2 and Anti-EpCAM to Increase the Capture Efficiency of Non-Small-Cell Lung Cancer Cell Lines in the Flow Enrichment Target Capture Halbach (FETCH) Magnetic Separation System.

Journal: International journal of molecular sciences

Published: August 09, 2024

Showing 1-12 of 114

Last Updated: 09/26/2026